Manuscripts
Showing 1543 manuscripts.
Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine.
Citation
Richardson KM, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ, P1086 team, Weinberg A, Muresan P. Determinants of Vaccine Immunogenicity in HIV-Infected Pregnant Women: Analysis of B and T Cell Responses to Pandemic H1N1 Monovalent Vaccine.. PLoS One. 2015. 10: e0122431. PMID: 25874544Year
2015
Journal
PLoS One
Study
P1086
Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High- Income Countries.
Citation
M Koller, B Chi, K Wools-Kaloustian, V Leroy, K Chokephaibulkit, C Chimbetete, D Avila, R Hazra, S Ayaya, F Dicko, HK Trong, M Egger, Mary-Ann Davies, Kunjal Pate. Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High- Income Countries.. Journal of Acquired Immune Deficiency Syndromes. 2015. 68: 62-72. PMID: 25501345Year
2015
Journal
Journal of Acquired Immune Deficiency Syndromes
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Citation
Jiajia Wang, Edmund V Capparelli, Sandra K Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Tim R Cressey, Lynne M Mofenson, Elizabeth Smith, David Shapiro, Mark Mirochnick, Alice Stek, Brookie M Best. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women. Journal of Acquired Immune Deficiency Syndromes. 2015. 70: 33-41. PMID: 25950206Year
2015
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1
Citation
Stephen A. Spector, Grant R. Campbell, Rachel S. Bruckman. Autophagy Induction by Histone Deacetylase Inhibitors Inhibits HIV Type 1. Journal of Biological Chemistry. 2015. 290: 5028-5040. PMID: 25540204Year
2015
Journal
Journal of Biological Chemistry
Resistance detected by pyrosequencing following zidovudine-monotherapy for
prevention of HIV-1 mother-to-child-transmission
Citation
I Beck, W Deng, P Britto, DE Shapiro, RE Bumgarner, JI Mullins, RB Van Dyke, G Jourdain, LM Frenkel, SC Olson, N Nqo-Giang-Huong. Resistance detected by pyrosequencing following zidovudine-monotherapy for prevention of HIV-1 mother-to-child-transmission. AIDS. 2015. 29: 1467-1471. PMID: 26244386Year
2015
Journal
AIDS
Study
P1032
Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women
Citation
Kabamba Kabeya, Mark Mirochnick, PANNA network and the IMPAACT 1026s study team, Jiajia Wang, Elizabeth Smith, Stein Schalkwijk, Alice Stek, Carmen Hidalgo Tenorio, David Hawkins, Graham Taylor, Regis Kreitchmann, Sandra Burchett, Annette Haberl, Marjo van Kasteren, Edmund Capparelli, David Burger, Angela Colbers, Brookie Best. Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women. Clinical Infectious Diseases. 2015. 61: 1582-1589. PMID: 26202768Year
2015
Journal
Clinical Infectious Diseases
Study
P1026S
Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women
Citation
Kelly Richardson, Terence Fenton, Teresa Dominguez, Anthony Bloom, D Heather Watts, Mark J Abzug, Sharon A Nachman, Myron J Levin for the P1086 study team, Adriana Weinberg , Petronella Muresan. Heterogeneity of T Cell Responses to Pandemic pH1n1 Monovalent Vaccine in HIV-Infected Pregnant Women. AIDS Research and Human Retroviruses. 2015. 31: 1170-7. PMID: 26322930Year
2015
Journal
AIDS Research and Human Retroviruses
Study
P1086
Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth
Citation
S Nachman, T Fenton, KM Richardson, T Dominguez, PM Flynn, SA Spector, CK Cunningham, A Bloom, A Weinberg, DJ Curtis, P Muresan. Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth. PLoS One. 2015. 3: e0118567. PMID: 25785995Year
2015
Journal
PLoS One
Study
P1088
Cost-effectiveness of first-line antiretroviral therapy for
HIV-infected African children less than three years of age
Citation
M Penazzato, JC Lindsey, L Harrison, K Kelly, RP Walensky, S Essajee, E Losina, L Muhe, K Wools-Kaloustian, S Ayaya, MC Weinstein, P Palumbo, KA Freedberg, AL Ciaranello, K Doherty. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than three years of age. AIDS. 2015. 29: 1247-1259. PMID: 25870982Year
2015
Journal
AIDS
Study
P1060
Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093
Citation
Terry Fenton, Edward P. Acosta, Rohan Hazra, Ellen O’Gara, Debra Steimers, Sherene Min, Andrew Wiznia on behalf of the P1093 study team., Rolando M. Viani, Carmelita Alvero. Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093. Pediatric Infectious Disease Journal. 2015. 34: 1207-1213. PMID: 26244832Year
2015
Journal
Pediatric Infectious Disease Journal
Study
P1093